Hinova Pharmaceuticals, Inc.   Report issue

For profit Phase 3
Founded: Sichuan China (2013)

Organization Overview

First Clinical Trial
2019
NCT03850795
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hinova Pharmaceuticals Inc. | Hinova Pharmaceuticals USA, Inc.